-+ 0.00%
-+ 0.00%
-+ 0.00%

CBIH Plans Expanded Research Into Endocannabinoid Science and Personalized Medicine

PUBT·10/19/2026 11:17:12
CBIH Plans Expanded Research Into Endocannabinoid Science and Personalized Medicine
  • Cannabis Bioscience International Holdings plans to expand research linking endocannabinoid biology with precision medicine to develop intellectual property with potential biomedical applications.
  • Planned studies will investigate cannabinoid interactions with cellular pathways involved in complex diseases, supporting potentially patentable technologies.
  • Anticipating proposed federal marijuana rescheduling from Schedule I to Schedule III, it intends to explore research partnerships and licensing agreements.
  • These initiatives target future commercialization through medical, pharmaceutical and biotechnology organizations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cannabis Bioscience International Holdings Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610190700NEWSFILECNPR____20261019_319667_1) on October 19, 2026, and is solely responsible for the information contained therein.